Health Canada – 2014-2015 – Supplementary Information Tables – Departmental Performance Report
Table of Contents
- Departmental Sustainable Development Strategy
- Overview of the Federal Government's Approach to Sustainable Development
- Themes I to III: Department-Led Targets
- Themes I to III: Implementation Strategies and Clean Air Agenda Financial Table
- Theme IV: Targets and Implementation Strategies
- Sustainable Development Management System
- Strategic Environmental Assessment
- Details on Transfer Payment Programs of $5 Million or More
- Contributions for First Nations and Inuit Health Infrastructure Support (Voted)
- Contributions for First Nations and Inuit Primary Health Care (Voted)
- Contributions for First Nations and Inuit Supplementary Health Benefits (Voted)
- Territorial Health Investment Fund (Voted)
- Anti-Drug Strategy Initiatives (Voted)
- Canada Brain Research Fund to Advance Knowledge for the Treatment of Brain Disorders (Voted)
- Canadian Blood Services: Blood Research and Development Program (Voted)
- Contribution to the Canadian Agency for Drugs and Technologies in Health (Voted)
- Contribution to the Canadian Institute for Health Information (Voted)
- Contribution to the Canadian Partnership Against Cancer (Voted)
- Contribution to the Canadian Patient Safety Institute (Voted)
- Grant to support the Mental Health Commission of Canada (Voted)
- Health Care Policy Contribution Program (Voted)
- Official Languages Health Contribution Program (Voted)
- Thalidomide Survivors Contribution Program (Voted)
- Horizontal Initiatives
- Internal Audits and Evaluations
- Response to Parliamentary Committees and External Audits
- Up-Front Multi-Year Funding
- User Fees, Regulatory Charges and External Fees
- Reporting on User Fees Act
- Fee Rights to Sell Drugs Fee
- Drug Establishment Licensing Fees
- Drug Submission Evaluation Fees (Pharmaceuticals and Biologic Products)
- Medical Device License Application Fees
- Fee for Right to Sell a Licensed Medical Device
- Medical Device Establishment Licensing Fees
- Veterinarian Drug Evaluation Fees
- Fees charged for filing a claim for exemption under the Hazardous Materials Information Review Act
- Pest Control Product Application Examination Service
- Right or Privilege to manufacture or sell a Pest Control Product in Canada and for Establishing a Maximum Residue Limit in relation to a Pest Control Product
- Fees for processing requests filed under the Access to Information Act
- Summary of Financial Information for All User Fees and Regulatory Charges
- Reporting on the Policy on Service Standards for External Fees
- Fee Rights to Sell Drugs Fee
- Certificates of Pharmaceutical Product (Drug Export) Fees
- Drug Establishment Licensing Fees
- Drug Master File Fees
- Drug Submission Evaluation Fees (Pharmaceuticals & Biologic Products)
- Medical Device Licence Application Fees
- Fees for Right to Sell a Licensed Medical Device
- Medical Device Establishment Licensing Fees
- Veterinary Drug Evaluation Fees
- Fees Charged for filing a claim under the Hazardous Material Information Reviews Act
- National Dosimetry Services Product (NDSP), Service and Fee Structure (S&F)
- Fees to be paid for Pest Control Product Application Examination Service
- Fees to be paid for the right or privilege to manufacture or sell a pest control product in Canada and for establishing a Maximum Residue Limit in relation to a pest control product
- Fees to be paid for the right of Employee Assistance Services (EAS)
- Reporting on User Fees Act
Organization: Health Canada
Date published: 2016-11-21
Report a problem or mistake on this page
- Date modified: